Burke Steven Keith 4
4 · Akebia Therapeutics, Inc. · Filed Feb 29, 2024
Insider Transaction Report
Form 4
Burke Steven Keith
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2024-02-27$1.52/sh−8,367$12,718→ 703,009 total
Footnotes (2)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.
- [F2]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023.